Login / Signup

Current Advances in Multiple Myeloma: A Post International Myeloma Society (IMS 2022) Round Table Debate by the International Academy for Clinical Hematology (IACH).

Nizar J BahlisLuciano J CostaThierry FaconJean-Luc HarousseauSalomon ManierAurore PerrotCyrille TouzeauMohamad Mohty
Published in: Clinical hematology international (2023)
This round table discussion organized by the International Academy for Clinical Hematology (IACH) was dedicated to the 19th annual meeting of the International Myeloma Society (IMS), which was held in Los Angeles between the 25th and 27th August 2022. After some key meetings of the discipline of the field of clinical hematology, the IACH organizes regular round table discussion in order to summarize the flow of information and get the opinion of a panel of experts and the key take-home messages. As part of this discussion, the panellists debated 6 key topics: disease monitoring, management of high-risk multiple myeloma (MM), induction for newly-diagnosed MM, management of relapsed MM, immune reconstitution, and vaccination and cellular therapy in MM.
Keyphrases
  • multiple myeloma
  • newly diagnosed
  • healthcare
  • acute myeloid leukemia
  • acute lymphoblastic leukemia
  • mesenchymal stem cells
  • replacement therapy
  • smoking cessation
  • cell therapy
  • social media